“Prostate Cancer Progresses Silently, Early Diagnosis and Regular Check-Ups Save Lives”
Prof. Dr. Gamze Gököz Doğu, Faculty Member of the Department of Medical Oncology at Pamukkale University (PAU) Hospitals, emphasized the importance of early diagnosis of prostate cancer on the occasion of September 15 World Prostate Cancer Awareness Day.
Prof. Dr. Gamze Gököz Doğu, Faculty Member of the Department of Medical Oncology at PAU Hospitals, shared the following information in her statement:
“Every year, September 15 is observed globally as World Prostate Cancer Awareness Day. This special day offers an important opportunity to draw attention to prostate cancer, one of the most critical issues in men’s health, to emphasize the life-saving importance of early diagnosis, and to encourage men to undergo regular check-ups. Prostate cancer is a disease that occurs with the uncontrolled growth of cancerous cells in the prostate gland, located below the urinary bladder in men. The prostate is an organ the size of a walnut and can grow with age; however, not every growth indicates cancer. Therefore, regular check-ups and biopsy when necessary are very important. Studies have identified several factors that increase the risk of prostate cancer. Age is the most important factor. Although prostate cancer is rarely seen under the age of 40, the likelihood increases rapidly after 50. Family history is also very significant; individuals whose father or brother had prostate cancer have a higher risk. Testosterone, the male hormone, can play a role in cancer development. Eating habits also have an effect. It is known that men who consume fatty foods, especially red meat and dairy products, have a slightly higher risk. Although obesity does not directly increase cancer risk, it raises the likelihood of developing a more aggressive, rapidly spreading type of prostate cancer.”
Prof. Dr. Gamze Gököz Doğu: “If You Have a Family History, Never Neglect Your Check-Ups”
Prof. Dr. Gököz Doğu emphasized that prostate cancer often does not show symptoms in early stages, making screening tests crucial. She stated that these tests aim to detect cancer before symptoms appear. Regarding these tests, current oncology guidelines recommend urological examination and PSA testing starting from age 45. Prof. Dr. Gamze Gököz Doğu explained that the PSA test measures the level of a protein produced by prostate cells in the blood, and elevated levels may indicate suspicion of prostate cancer. In addition, during a digital rectal examination, the urology specialist assesses the prostate with their finger to check for any hardness or mass. For a definitive diagnosis, a prostate biopsy must be performed, which is the only way to confirm prostate cancer.
Prof. Dr. Gököz Doğu continued:
“Early-stage prostate cancer often shows no symptoms; however, in advanced stages, symptoms such as difficulty urinating, blood in urine or semen, erectile problems, and bone pain may appear. Individuals with any of these symptoms should consult a doctor immediately. After a prostate cancer diagnosis, treatment options are determined individually for each patient. These include surgery, radiotherapy, hormone therapies, chemotherapy, immunotherapy, targeted therapies, and radioactive substances. The physician and patient should evaluate in detail the risks, side effects, and benefits of each option to make the most appropriate decision. September 15, World Prostate Cancer Awareness Day, serves as an important reminder for all men. Do not postpone your health and make sure to undergo regular check-ups.”